Tag Archives: ACC

Tales from the Road: ACC 2015

Our participation in the American College of Cardiology 64th annual Scientific Sessions last month in San Diego appears to have been very successful. The traffic to our booth was extremely high and a large number of visitors, from the United States and overseas, expressed interest in our products. Attendees were curious in our core technology EECP® (Enhanced External Counterpulsation) therapy and our growing patient monitoring product line.

Additionally, Dr. Joseph Tartaglia on behalf of his co-authors from the New York Medical College in Valhalia, New York presented a poster abstract on EECP® Therapy and the positive effect it has on decreasing the risk of Major Adverse Cardiac Events (referred to as MACE) for patients. The poster was titled “Patients That Respond to Enhanced External Counterpulsation Are at Decreased Risk for Major Adverse Cardiac Events and Have Increases in Endothelial Precursor Stem Cells”. The study, which followed up on the participating patients for 96 months, demonstrated that these patients had an increase in exercise capacity post treatment and had fewer major adverse cardiac events after treatment. It showed that patients with increased exercise capacity also had an increase in peripheral endothelial precursor CD133+ cells. This suggests, according to the authors, that the new collateral vessel development resulting from the EECP® treatment is responsible for the improved outcomes.

Our next exhibition will be at the Hospitalar meeting in Sao Paulo, Brazil in May. We look forward to showcase our EECP Therapy and our patient monitoring product line to the growing medical industry in Latin America.

Tales from the Road – American College of Cardiology Scientific Sessions in Washington, DC

We just returned from the nation’s capital after three days of participation at the American College of Cardiology (ACC) 63rd Scientific Sessions. Based upon our numerous meetings and conversations with physicians and industry attendees, we thought this was a very successful event.

Our booth received a steady stream of visitors who expressed interest in Vasomedical’s current products and services. We also had the opportunity to speak to attendees about the direction our company is going to meet the future needs of healthcare markets globally.

Our live demonstrations of EECP Therapy attracted physicians who were on their way to poster presentations and program sessions, and even drew the attention of some on their way out of the convention center en route to enjoy visiting the many sights D.C. has to offer. In addition to EECP Therapy, there was significant interest in both our BIOX ambulatory ECG and blood pressure monitoring products and the new wireless vital signs monitoring products MobiCare™.

The EECP abstract presented on Saturday morning received good reviews from physicians who attended the presentation, many of which visited our booth afterward to learn more about our innovative therapy and the company. We made many new clinical as well as business development contacts at the show and we will be busy in the coming weeks following up with these folks.

Did you attend the ACC Scientific Sessions?  If so, what was the most interesting thing you saw, experienced or heard at the show? Email us at vaso@kcsa.com to let us know.